Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...

There are 15 Connecticut-headquartered companies that made the 2025 Fortune 500 list of largest U.S. corporations. Here's the ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of ... ruling that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be made ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...